Scottish Medicines Consortium publishes guidance on 12 treatments (National Health Executive) - Oct 11, 2023 - "SMC advises on newly-licensed medicines for launch in NHS Scotland and recently published guidance on a total of 12 treatments....The committee also accepted atogepant (Aquipta) for adults who have more than four migraines a month....SMC ruled that adults with lupus nephritis, a disease which causes the immune system to attack the kidneys, can now be treated with voclosporin (Lupkynis)."
Reimbursement • CNS Disorders • Immunology • Lupus Nephritis • Migraine • Pain
|